Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)

Ann Hematol. 2021 Apr;100(4):1107-1109. doi: 10.1007/s00277-020-04247-4. Epub 2020 Sep 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anaplastic Lymphoma Kinase / metabolism*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Humans
  • Ki-1 Antigen / metabolism*
  • Lymphoma, Large-Cell, Anaplastic / diagnosis*
  • Lymphoma, Large-Cell, Anaplastic / diagnostic imaging
  • Lymphoma, Large-Cell, Anaplastic / drug therapy
  • Lymphoma, Large-Cell, Anaplastic / pathology*
  • Magnetic Resonance Imaging
  • Positron Emission Tomography Computed Tomography
  • Prednisolone / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Ki-1 Antigen
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • ALK protein, human
  • Anaplastic Lymphoma Kinase

Supplementary concepts

  • CHOEP protocol